The first two authors contributed equally to this work.
1530-0277/asset/olbannerleft.gif?v=1&s=2e5fd2ba9d30fe020968aa2d45502ae2c30e70f4)
1530-0277/asset/olbannerright.gif?v=1&s=c16273570372799a0e98ebc8a00aae11b61ab296)
Original Article
You have free access to this content
Thromboxane Inhibitors Attenuate Inflammatory and Fibrotic Changes in Rat Liver Despite Continued Ethanol Administrations
Article first published online: 7 JUN 2012
DOI: 10.1111/j.1530-0277.2012.01838.x
Copyright © 2012 by the Research Society on Alcoholism
Additional Information
How to Cite
Nanji, A. A., Liong, E. C., Xiao, J. and Tipoe, G. L. (2013), Thromboxane Inhibitors Attenuate Inflammatory and Fibrotic Changes in Rat Liver Despite Continued Ethanol Administrations. Alcoholism: Clinical and Experimental Research, 37: 31–39. doi: 10.1111/j.1530-0277.2012.01838.x
Publication History
- Issue published online: 4 JAN 2013
- Article first published online: 7 JUN 2012
- Manuscript Accepted: 20 MAR 2012
- Manuscript Received: 28 NOV 2011
Funded by
- National Institutes of Health. Grant Number: AA 12893
- The University of Hong Kong
- Research Grants Council of the Hong Kong SAR. Grant Number: HKU 7340/00 MM
References
- , , , , , (1985) CGS 12970: a novel, long acting thromboxane synthetase inhibitor. Br J Pharmacol 86:497–504.
- (1998) IkappaB-NF-kappaB structures: at the interface of inflammation control. Cell 95:729–731.
- , (2010) Mechanisms and cell signaling in alcoholic liver disease. Biol Chem 391:1249–1264.
- , (1959) A rapid method of total lipid extraction and purification. Can J Biochem Physiol 37:911–917.
- , , (2002) DLPC decreases TGF-beta1-induced collagen mRNA by inhibiting p38 MAPK in hepatic stellate cells. Am J Physiol Gastrointest Liver Physiol 283:G1051–G1061.
- , , , , (2009) Oxidative stress, isoprostanes and hepatic fibrosis. Histol Histopathol 24:893–900.
- , (2001) Ethanol consumption and liver mitochondria function. Biol Signals Recept 10:271–282.
- , , , , , (2006) Chronic ethanol-mediated decrease in cAMP primes macrophages to enhanced LPS-inducible NF-kappaB activity and TNF expression: relevance to alcoholic liver disease. Am J Physiol Gastrointest Liver Physiol 291:G681–G688.
- , , , , , , , , , , (2003) Ethanol induces transforming growth factor-alpha expression in hepatocytes, leading to stimulation of collagen synthesis by hepatic stellate cells. Alcohol Clin Exp Res 27:58S–63S.
- (1992) Eicosanoids: potential regulators of extracellular matrix formation in the kidney. J Lab Clin Med 120:4–6.
- (2004) Alcoholic fatty liver: its pathogenesis and mechanism of progression to inflammation and fibrosis. Alcohol 34:9–19.
- , , , , (1995) Vitamin E therapy of acute CCl4-induced hepatic injury in mice is associated with inhibition of nuclear factor kappa B binding. Hepatology 22:1474–1481.
- , (2009) Signalling pathways in alcohol-induced liver inflammation. J Hepatol 50:1258–1266.
- , , (2003) The epidemiology of alcoholic liver disease. Alcohol Res Health 27:209–219.
- , , (2007) Effect of ethanol on pro-apoptotic mechanisms in polarized hepatic cells. World J Gastroenterol 13:4960–4966.
- , , , , , , (1999) Alcohol-induced generation of lipid peroxidation products in humans. J Clin Invest 104:805–813.
- , , , , , , , (1995) Modulation of experimental alcohol-induced liver disease by cytochrome P450 2E1 inhibitors. Hepatology 21:1610–1617.
- (2006) The isoprostanes—unique products of arachidonate peroxidation: their role as mediators of oxidant stress. Curr Pharm Des 12:895–902.
- , , , , , , , (1999) Activation of nuclear factor kappa B and cytokine imbalance in experimental alcoholic liver disease in the rat. Hepatology 30:934–943.
- , , , , , (1997a) Thromboxane inhibitors attenuate pathological changes in alcoholic liver disease in the rat. Gastroenterology 112:200–207.
- , , , (1994) Plasma levels of a novel noncyclooxygenase-derived prostanoid (8-isoprostane) correlate with severity of liver injury in experimental alcoholic liver disease. J Pharmacol Exp Ther 269:1280–1285.
- , , , , , , (1997b) Cholesterol supplementation prevents necrosis and inflammation but enhances fibrosis in alcoholic liver disease in the rat. Hepatology 26:90–97.
- , , , (1995) Role for transforming growth factor beta in thromboxane-induced increases in mesangial cell fibronectin synthesis. Diabetes 44:335–339.
- , , (1997) Evidence for the formation of F3-isoprostanes during peroxidation of eicosapentaenoic acid. Biochem Biophys Res Commun 236:467–472.
- , , , , (1993) Pharmacological profile of BMS 180,291: a potent, long-acting, orally active thromboxane A2/prostaglandin endoperoxide receptor antagonist. J Pharmacol Exp Ther 264:570–578.
- , , , (2001) The isoprostanes in biology and medicine. Trends Endocrinol Metab 12:243–247.
- , (1984) Spectrophotometric detection of lipid conjugated dienes. Methods Enzymol 105:331–337.
- , , , , , (2009) Global burden of disease and injury and economic cost attributable to alcohol use and alcohol-use disorders. Lancet 373:2223–2233.
- , , (2000) Pronounced hepatic free radical formation precedes pathological liver injury in ethanol-fed rats. Alcohol Clin Exp Res 24:332–335.
- , , , , , , , (1998) Formation of isoprostane-like compounds (neuroprostanes) in vivo from docosahexaenoic acid. J Biol Chem 273:13605–13612.
- , , (2001) Ifetroban sodium: an effective TxA2/PGH2 receptor antagonist. Cardiovasc Drug Rev 19:97–115.
- , (2000) NF-kappaB/rel/IkappaB: implications in gastrointestinal diseases. Gastroenterology 118:1208–1228.
- , (2001) Why there are two cyclooxygenase isozymes. J Clin Invest 107:1491–1495.
- , , (2009) Inflammatory pathways in liver homeostasis and liver injury. Clin Rev Allergy Immunol 36:4–12.
- (1998) II. Alcoholic liver injury involves activation of Kupffer cells by endotoxin. Am J Physiol 275:G605–G611.
- (1999) Cytokine regulation of hepatic stellate cells in liver fibrosis. Alcohol Clin Exp Res 23:911–916.
- , , , (1986) Ethanol-induced liver fibrosis in rats fed high fat diet. Hepatology 6:814–822.
- , , , , (2005) Role of thromboxane in producing hepatic injury during hepatic stress. Arch Surg 140:801–807.